JPRN-UMIN000009583已完成2 期
Phase II study of neoadjuvant mFOLFOX6 (+ cetuximab) in patients with resectable pelvic recurrences after rectal cancer surgery - Phase II of NAC with mFOLFOX6 (+ Cmab)
ational Cancer Center Hospital East0 个研究点目标入组 33 人开始时间: 2012年12月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval 2) Severe infectious disease 3) Patients who receive steroid continuously are excluded 4) Unstable angina or myocardial infarction within 6 months 5) Interstitial pneumonia or fibroid lung 6) Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test 7) Those considered inappropriate for participation in this trial.
研究者
相似试验
已完成
2 期
Feasibility study of neoadjuvant mFOLFOX6 plus cetuximab in patients with resectable liver limited metastases from colorectal cancer harboring KRAS wild typeMetastatic colorectal cancerJPRN-UMIN000007545ational Cancer Center Hospital East20
招募中
2 期
Multicenter phase II trial of mFOLFOX6 with cetuximab as active chemotherapy regimen for liver metastases inappropriate for curative resection in EGFR positive and KRAS wild type colorectal cancerEGFR positive and KRAS wild type colorectal cancer with liver metastases inappropriate for curative resectionJPRN-UMIN000004683Tohoku - Six Universities Research Group by Experts (T-SURGE)50
招募中
2 期
Phase II study of Cetuximab with mFOLFOX6 treatment in patients with previously untreated Rectal cancerRectal CancerJPRN-UMIN000010791PO FMPC (Future Medicine Promoting Consortium)25
已完成
2 期
Multicancer Phase II study of mFOLFOX6 as Neoadjuvant chemotherapy for T3 or T4 Stage II / III rectal cancerRectal CancerJPRN-UMIN000006583Tokyo Women's Medical University Hospital50
已完成
2 期
Phase II trial of adjuvant mFOLFOX6 after metastasectomy for lung metastasis of colorectal cancerColorectal cancerJPRN-UMIN000005693West Japan Oncology Group100